You are here: Industry Insights > Remdesivir

News List

Gilead Sciences to support expansion of local production capacity of Remdesivir in India expresspharma
April 28, 2021
Gilead will donate a minimum of 450,000 vials of Veklury to the Government of India.
Jubilant Pharma subsidiary announces development of novel oral formulation of Remdesivir expresspharma
April 20, 2021
Jubilant Pharma, a subsidiary of Jubilant Pharmova, announces successful completion of safety and pharmacokinetic/absorption studies in animals and healthy human volunteers in India using a novel oral formulation of remdesivir against the commercially ...
Remdesivir’s price must not be more than Rs 1400 per vial: Maha Health Minister expresspharma
April 12, 2021
Tope said with a rapid rise in COVID-19 cases, the state may need 1.5 lakh Remdesivir injections daily which would require ramping up of production.
Centre bans exports of remdesivir until COVID situation gets better expresspharma
April 12, 2021
In view of increased demand for remdesivir due to a surge in COVID-19 cases, the Centre said the export of the antiviral injection and its Active Pharmaceutical Ingredients (API) has been banned till the situation improves.
Lilly, Incyte report trial results of baricitinib in Covid-19 patients pharmaceutical-technology
April 09, 2021
Eli Lilly and Incyte have reported that the Phase III COV-BARRIER study of baricitinib failed to meet statistical significance on the primary endpoint of progression to non-invasive ventilation or invasive mechanical ventilation or death in ...
Ramp up remdesivir manufacturing to full capacity: Govt to pharma firms expresspharma
April 09, 2021
Mansukh Mandaviya said seven manufacturers - Mylan, Hetero, Jubiliant Life Sciences, Cipla, Dr Reddy's, Zydus Cadila and Sun Pharma - have a monthly production capacity of 31.60 lakh vials.
Study identifies possible COVID-19 drugs - including several that are FDA-approved worldpharmanews
April 08, 2021
A team led by scientists in the Perelman School of Medicine at the University of Pennsylvania has identified nine potential new COVID-19 treatments, including three that are already approved by the Food and Drug Administration (FDA) for treating other ...
FDA Provides Specific Compounded Drug Concerns Related to COVID-19 americanpharmaceuticalreview
February 26, 2021
The U.S. Food and Drug Administration (FDA) is advising compounders and health care providers the agency has concerns about the use of certain drugs prepared by compounders to treat patients with COVID-19.
FDA Announces Alert of Potential Risks Associated with Compounding of Remdesivir americanpharmaceuticalreview
February 08, 2021
The U.S. Food and Drug Administration (FDA) approved a new drug application (NDA) for Veklury (remdesivir), a drug indicated for adults and pediatric patients (12 years of age and older and weighing at least 40 kg) for the treatment of COVID-19 ...
New England Journal of Medicine publishes COVID-19 treatment trial results worldpharmanews
January 18, 2021
A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results ...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page